Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway.
AffiliationRespiratory Research Division, Department of Medicine, Royal College of Surgeons , in Ireland, Beaumont Hospital, Dublin 9, Ireland.
MeSHBronchoalveolar Lavage Fluid/cytology
Receptor, Epidermal Growth Factor/metabolism
MetadataShow full item record
CitationJ Biol Chem. 2011 Mar 4;286(9):7692-704. Epub 2010 Dec 30.
JournalThe Journal of biological chemistry
AbstractA high intrapulmonary protease burden is characteristic of cystic fibrosis (CF), and the resulting dysregulation of the protease/anti-protease balance has serious implications for inflammation in the CF lung. Because of this inflammation, micro-bleeds can occur releasing hemoglobin into the lung. The aim of this study was to investigate the effect of the protease-rich environment of the CF lung on human hemoglobin and to assess the proinflammatory effect of heme on CF bronchial epithelium. Here, we show that the Pseudomonas proteases (Pseudomonas elastase and alkaline protease) and the neutrophil proteases (neutrophil elastase (NE) and proteinase-3) are capable of almost complete degradation of hemoglobin in vitro but that NE is the predominant protease that cleaves hemoglobin in vivo in CF bronchoalveolar lavage fluid. One of the effects of this is the release of heme, and in this study we show that heme stimulates IL-8 and IL-10 protein production from DeltaF508 CFBE41o(-) bronchial epithelial cells. In addition, heme-induced IL-8 expression utilizes a novel pathway involving meprin, EGF receptor, and MyD88. Meprin levels are elevated in CF cell lines and bronchial brushings, thus adding to the proinflammatory milieu. Interestingly, alpha(1)-antitrypsin, in addition to its ability to neutralize NE and protease-3, can also bind heme and neutralize heme-induced IL-8 from CFBE41o(-) cells. This study illustrates the proinflammatory effects of micro-bleeds in the CF lung, the process by which this occurs, and a potential therapeutic intervention.
- TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
- Authors: Greene CM, Carroll TP, Smith SG, Taggart CC, Devaney J, Griffin S, O'neill SJ, McElvaney NG
- Issue date: 2005 Feb 1
- Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway.
- Authors: Bergin DA, Greene CM, Sterchi EE, Kenna C, Geraghty P, Belaaouaj A, Taggart CC, O'Neill SJ, McElvaney NG
- Issue date: 2008 Nov 14
- miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.
- Authors: Weldon S, McNally P, McAuley DF, Oglesby IK, Wohlford-Lenane CL, Bartlett JA, Scott CJ, McElvaney NG, Greene CM, McCray PB Jr, Taggart CC
- Issue date: 2014 Jul 15
- TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.
- Authors: John G, Yildirim AO, Rubin BK, Gruenert DC, Henke MO
- Issue date: 2010 Apr
- The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10.
- Authors: Dosanjh AK, Elashoff D, Robbins RC
- Issue date: 1998 Oct